Novant Health Cancer Institute- Hematology

Charlotte, North Carolina 28204

1 studies enrolling now · 3 studies all time

What they study most

Blastic Plasmacytoid Dendritic Cell Neoplasm, High-risk Large B-cell Lymphoma (LBCL), Large B-cell Lymphoma, Myeloproliferative Neoplasm

Studies at this site

• Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL — Recruiting now
• Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma — Running, not enrolling
• Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN — Running, not enrolling